1. Home
  2. RRBI vs ALT Comparison

RRBI vs ALT Comparison

Compare RRBI & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RRBI
  • ALT
  • Stock Information
  • Founded
  • RRBI 1998
  • ALT 1997
  • Country
  • RRBI United States
  • ALT United States
  • Employees
  • RRBI N/A
  • ALT N/A
  • Industry
  • RRBI Hotels/Resorts
  • ALT Biotechnology: Pharmaceutical Preparations
  • Sector
  • RRBI Consumer Discretionary
  • ALT Health Care
  • Exchange
  • RRBI Nasdaq
  • ALT Nasdaq
  • Market Cap
  • RRBI 406.6M
  • ALT 327.4M
  • IPO Year
  • RRBI 2019
  • ALT N/A
  • Fundamental
  • Price
  • RRBI $65.34
  • ALT $3.57
  • Analyst Decision
  • RRBI Buy
  • ALT Strong Buy
  • Analyst Count
  • RRBI 1
  • ALT 6
  • Target Price
  • RRBI $67.00
  • ALT $17.40
  • AVG Volume (30 Days)
  • RRBI 12.5K
  • ALT 2.3M
  • Earning Date
  • RRBI 10-29-2025
  • ALT 11-11-2025
  • Dividend Yield
  • RRBI 0.74%
  • ALT N/A
  • EPS Growth
  • RRBI 23.60
  • ALT N/A
  • EPS
  • RRBI 5.67
  • ALT N/A
  • Revenue
  • RRBI $115,623,000.00
  • ALT $20,000.00
  • Revenue This Year
  • RRBI $5.20
  • ALT N/A
  • Revenue Next Year
  • RRBI $17.47
  • ALT $761,880.20
  • P/E Ratio
  • RRBI $11.38
  • ALT N/A
  • Revenue Growth
  • RRBI 10.19
  • ALT N/A
  • 52 Week Low
  • RRBI $46.33
  • ALT $2.90
  • 52 Week High
  • RRBI $66.50
  • ALT $11.16
  • Technical
  • Relative Strength Index (RSI)
  • RRBI 55.92
  • ALT 44.06
  • Support Level
  • RRBI $64.05
  • ALT $3.54
  • Resistance Level
  • RRBI $65.69
  • ALT $3.72
  • Average True Range (ATR)
  • RRBI 1.02
  • ALT 0.16
  • MACD
  • RRBI -0.12
  • ALT 0.01
  • Stochastic Oscillator
  • RRBI 55.21
  • ALT 10.94

About RRBI Red River Bancshares Inc.

Red River Bancshares Inc is the bank holding company for the red river bank. The principal business of the Bank is lending and accepting deposits from businesses, professionals, individuals, and public entities. The bank's primary deposit products are demand deposits, savings deposits, and time deposits. The bank maintains a diversified loan portfolio with a focus on commercial real estate (Owner Occupied and Non-Owner Occupied), one-to-four-family residential, commercial, and industrial loans, construction and development Loans, and others. also, provides Treasury Management Services, Private Banking Services, Brokerage Services, and Other Banking Services.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: